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Face and head morphogenesis begin early in develop-
ment, when the brain is beginning to form, and are highly
dependent on patterning information provided by emi-
grant cranial neural crest cells [1]. These cells generate
most of the bones and cartilage in the head, and instruct
paraxial mesoderm in the formation of appropriate muscu-
lature [2]. Molecular cues that differ spatiotemporally
along the rostrocaudal axis of the early brain plate affect
emerging cranial neural crest cells and predetermine some
aspects of their fate, such as whether they generate first or
second branchial arch skeletal elements.
Progress in understanding craniofacial development is
being greatly facilitated by the recently developed ability
to create ‘knockout’ mice in which a specific gene has
been inactivated by homologous recombination. A sub-
stantial number of such knockout experiments have iden-
tified genes that are essential for craniofacial development.
Many of these genes code for DNA-binding transcription
factors, and almost all are expressed in specific subregions
of cranial neural-crest-derived mesenchyme. Although
there is an experimental bias towards knocking-out genes
for transcription factors, it is also probably significant that
loss of a transcription factor can affect the expression of
multiple target genes.
Development of the jaws
Finding that knocking out a particular gene affects cranio-
facial development has frequently come as a surprise. One
good example is provided by knockout mice that lack
expression of endothelin-1 (ET-1) [3], a vasoactive
peptide that is expressed in vascular endothelial cells and
is thought to be involved in the regulation of blood pres-
sure. Surprisingly, ET-1–/– mutant mice exhibited no
obvious problems in heart or vasculature development, but
instead they showed a significant reduction in size of the
mandible (lower jaw) and tongue. A retrospective exami-
nation of expression patterns in early embryos showed that
ET-1 is expressed in oral epithelium in 9.5 day embryos,
whereas ET-1 receptors are expressed in nearby
osteogenic mesenchyme of the mandibular prominence
[4]. Thus, in developing a model for mandibular pattern-
ing, it will now be important to include endothelin-1 as an
important morphogenetic molecule.
Mandibular development is affected in several other types
of knockout mice, including activin receptor type II [5],
goosecoid (gsc) [6,7], Hoxa2 [8,9], MHox [10] and Msx-1 [11]
mutants; the last four genes all encode homeobox domain
transcription factors. The mandible has a distinct mor-
phology, with four recognizable processes: the angular,
coronoid, condylar and dentoalveolar processes (Fig. 1).
Mutant gsc–/– mice lack the coronoid and angular
processes, whereas MHox–/– mice have deficient condylar,
angular and coronoid processes. MHox–/– mutants also lack
the squamosal bone and the temporo-mandibular joint,
which normally forms by the articulation of the condylar
process with the squamosal bone. MHox and gsc may
Figure 1
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The morphology of the mandible in wild-type mice compared to those in gsc–/– and MHox–/– mutants.
encode region-specific regulators of bone morphogenetic
proteins (BMPs) — signalling molecules of the transform-
ing growth factor b (TGF-b) family that are known to play
important developmental roles. As MHox–/– and gsc–/–
mutant mice survive until birth, bone morphogenesis in
these mice can be studied at all stages of development.
Analysis of the promoter regions of genes encoding BMPs
or their receptors may suggest whether they are directly
regulated by the MHox or gsc gene products.
Msx-1 is highly expressed in the distal parts of all growing
facial prominences. It was originally proposed that Msx-1
might play a role in fusion of the primary palate; however,
Msx-1–/– mutant mice have normal upper lips [11]. The
major craniofacial defect in these mice is a reduction in
size of the dentoalveolar process, and missing or delayed
development of the teeth. In humans, when teeth are con-
genitally missing or extracted, the alveolar bone is lost.
Thus, the role of Msx-1 in the development or mainte-
nance of the alveolar bone may be secondary to its func-
tion in molar development. Msx-1/Msx-2 double mutants
exhibit a more severe facial phenotype, and many deriva-
tives of the facial prominences are reduced or absent in
such mice (R. Maas, personal communication). Msx family
genes appear to be involved in epithelial–mesenchymal
interactions during facial and dental development, and
their expression may be regulated by BMPs [12].
The gene Dlx-2, which also encodes a homeodomain
protein, is uniformly expressed in the epithelium and
neural-crest-specific mesenchyme of the first branchial
arch. Surprisingly, inactivation of Dlx-2 affects proximal
derivatives of the first arch (including the maxilla), but
has no effect on the mandible [13]. There are at least five
Dlx family genes in the mouse, and it seems likely that
other family members can compensate for loss of Dlx-2
expression in the mandible.
Facial clefting
In order to interpret the phenotype of a strain of knockout
mice, it is necessary to identify the particular set of cells
that normally express the inactivated gene. Knowledge of
where the gene is expressed and the nature of its product
can provide strong clues as to whether the effects of the
mutation are cell-autonomous or non-cell-autonomous —
that is, whether inactivation of the gene affects the devel-
opmental fate of the cells where the gene is normally
expressed or of other cells that rely in some way on the
gene-expressing cells (or both). Such information can also
suggest testable models for the morphogenetic process that
has been disrupted in the knockout mice. These consider-
ations are well illustrated by the effects of targeted gene
inactivation on facial clefting.
Clefts of the secondary palate (the roof of the mouth) are
believed to occur when growth of the upper and lower
jaws is not coordinated properly (Fig. 2). For example, the
exposure of rat embryos to the teratogen diazo-oxo-nor-
leucine retards mandibular growth so that the tongue
remains wedged between the palatal shelves [14], result-
ing in a cleft palate. Mice lacking expression of gsc [6,7],
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develop cleft secondary palates and have mandibles that
are smaller than normal. Cleft secondary palate may
therefore be an indirect result of an early deficiency in
mesenchyme in the mandibular prominence.
Genes that may directly affect the growth of palatal shelves
include Dlx-2 [13] and MHox [10], and those encoding the
transcription factor AP-2 ([15] and H. Schorle, P. Meier, M.
Buchert, R. Jaenisch and P.J.M., unpublished data) and the
retinoic acid receptors (RARs) a and g [16]. With the
exception of AP-2, mutations of all these genes permit
normal elevation of the palatal shelves, but because of their
reduced size the medial edges cannot make contact. In AP-
2–/– mutant embryos, head morphogenesis is so severely
disrupted that it is difficult to discern the palatal shelves. In
wild-type embryos, AP-2 is expressed very early in cranial
neural-crest cells and in the crest-derived mesenchyme of
the facial prominences, as well as in the ectoderm [15]. The
regulation by AP-2 of multiple, critical target genes in
these cell types during embryogenesis may account for the
severity of the AP-2 mutant phenotype. 
In 9 day AP-2–/– embryos, increased cell death has been
observed to occur in proximal mesenchyme of the first
branchial arch and in brain plate neuroepithelia, and may
reflect cell autonomous and/or non-autonomous roles for
AP-2 in survival of these cells. It is tempting to speculate
that the neuroepithelial cell death is the direct cause of the
subsequent exencephaly — exposure of brain tissues
caused by failure of the cranial portion of the neural tube to
close — seen in these mice. In any event, changes extrinsic
to the neuroepithelial cells — that is, non-autonomous
changes — must ultimately underlie their death, as they do
not normally express AP-2 at this time [15].
In mutants lacking TGF-b3 [17,18] or activin bA/bB [19]
expression, the cleft-palate phenotype is only partially
penetrant, and the palatal shelves may be affected only
after they have met at the midline. During normal sec-
ondary palate development, the medial-edge epithelia of
the apposing palatal shelves touch and the mesenchyme
invades the seam, ultimately forming a continuous bridge
across the roof of the oral cavity. TGF-b3 is expressed in a
highly localized manner in the medial-edge epithelia of
the palatal shelves [20], and in TGF-b3 mutants the
epithelial seam persists in some regions of the palate, pre-
venting complete mesenchymal fusion. Although the
palate appears intact on macroscopic inspection, closer
examination reveals that the palatine bones do not meet in
the midline (termed a submucous cleft). Thus, it appears
that TGF-b3 is critical for fusion of the secondary palate
after the shelves have made initial contact.
Clefts involving the primary palate and upper lip are rare
(Fig. 3). Examples of this type of cleft are seen in AP-2–/–
mutants (H. Schorle, P. Meier, M. Buchert, R. Jaenisch
and P.J.M., unpublished data), and RARa/g [16] and
Msx-1/Msx-2 double mutants (R. Maas, personal communi-
cation). Msx-1/Msx-2 double-mutant mice have exen-
cephaly in combination with bilateral cleft upper lip and
cleft secondary palate. These mice may prove to be useful
models for human cleft lip and cleft palate disorders. In
contrast, the AP-2 and RAR mutants exhibit midline clefts
that are not analogous to the more common form of cleft
lip seen in humans and certain strains of mice. Midline
clefting may be caused by the absence, deficiency or
improper growth trajectory of the frontonasal and medial
nasal prominences.
AP-2–/– mutant mice suffer from severe exencephaly
(cranioschisis) involving the entire brain (H. Schorle, P.
Meier, M. Buchert, R. Jaenisch and P.J.M., unpublished
data). In this case, it is possible that midline clefting is a
secondary effect of abnormal brain growth, as the fron-
tonasal region is disturbed early in its formation by rostro-
ventral growth of the everted forebrain. The midline cleft
lip and other associated frontonasal region defects
observed in RARa/g double mutant mice are suggestive of
a deficiency in medial and frontonasal mesenchyme, pos-
sibly because of increased cell death in this region [16].
Fusion of the neural folds occurs normally in the fore-
brain, although about 50 % of the embryos have smaller
than normal frontal lobes. There is also a possibility that
the abnormal brain growth in RARa/g double mutant mice
is correlated with the midline cleft, as in AP-2–/– mice.
Figure 3
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Exencephaly also occurs in mice homozygous for a muta-
tion in twist, which encodes a helix–loop–helix domain
transcription factor expressed in cranial neural crest cells
and other mesodermal cell types [21]. These mice die at
around embryonic day 11.5, apparently of cardiovascular
defects. As this stage is sufficiently late for incipient cells
of the primary palate to be detected [22], it should be pos-
sible to see whether the open neural tube in twist mutant
embryos affects fusion of the facial prominences.
Future prospects
The phenotype of a strain of knockout mice reflects the
sum of the functions of the inactivated gene at all stages of
development. While the phenotype is sometimes stun-
ning, it is nonetheless of limited use for understanding
late functions of genes that are used at multiple times
during development, as abnormal early development may
mask the gene’s later roles. Furthermore, a gene may be
expressed in several interacting cell types, so that a partic-
ular phenotypic defect could be dependent on deficien-
cies in any or all of the cell types. On-going and future
developments in knockout-mouse technology may help to
resolve such complexities
The generation of chimeric mice by injecting mutant
embryonic stem cells into wild-type blastocysts may help
identify particularly important sites of expression of the
inactivated gene (see [21]) — for example, the presence of
mutant cells in a particular tissue may be found to correlate
with an aspect of the mutant phenotype. Finally, it is now
feasible to try to eliminate a gene product in a spatio-tempo-
rally regulated manner during ontogeny, using the Cre–loxP
recombination system [23]. This powerful technology will
no doubt be applied to the study of craniofacial develop-
ment in the future, and may provide more information
about the roles of various genes in facial morphogenesis.
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